A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women

Completed

Conditions studied: Preeclampsia, Maternal, Hypertension, Pregnancy

In brief

Primary Endpoint: Quantify the hemodynamic changes in preeclampsia using the non-invasive Nexfin device. Secondary Endpoint: Determine if measurable hemodynamic changes are statistically correlated with B-type natriuretic peptide (BNP) levels.

Key facts

Study ID

NCT02527018

Run by

University of California, Irvine

People needed

66

Starts

2014-11-01

Expected to finish

2017-10-01

Last updated by the study team

2018-01-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant women aged (x> or =18) with or without preeclampsia.
• Subjects with preeclampsia must have either mild or severe preeclampsia
• Healthy subjects should be normotensive
• Gestational age between 28 weeks to 40 0/7 weeks

You may not qualify if…

• Pregnant women aged (x<18)
• Pregnant women with multiple gestations
• Diagnosis of cardiac disease
• Diagnosis of vascular disease
• Diagnosis of end stage renal disease
• Subjects in active labor
• Diagnosis of Systemic Lupus Erythematosus or any other autoimmune disease
• Fetus' known to have age abnormality

Where it is running

• University of California, Department of OBGYN — Orange, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.